Endocrinological Changes Due to Pre-medications of Chemotherapy in Patients With Breast Cancer
Status:
Active, not recruiting
Trial end date:
2025-03-27
Target enrollment:
Participant gender:
Summary
Treatment for patients with high-risk breast cancer diagnoses is based on chemotherapy drugs
with side effects. Dexamethasone is a drug that is part of the arsenal of pre-chemotherapy
medications to prevent adverse events resulting from treatment, however common endocrine
pathological conditions resulting from high doses of this corticoid are clinically evident in
these individuals. The aim of this study is to evaluate the omission of corticosteroid doses
as a pre-medication in cancer treatment after the second week of treatment with taxane in a
curative setting.